Skip to main content

Labcorp Message (as of July 21, 4:00 p.m. ET)

  • All Labcorp core systems impacted by the CrowdStrike issues are currently back online.
  • Some of our patient service centers and in-office labs may be experiencing technical issues with retrieving orders.
  • We are working hard to resolve this issue.
  • If you have a copy of your order, this will help expedite the process.
  • We appreciate your patience as we work to restore business operations.

Oncology (nonclinical)

With more than 6,000 studies completed, we have amassed extensive experience and deep insights to inform end-to-end preclinical oncology research. Start your study quickly and expedite the development of your next potentially life-saving compound.

A full suite of molecular and cellular biology assays, off-the-shelf or custom

When your research has the potential to save lives, you deserve a partner with the oncology pharmacology knowledge, breadth of tools and experience to help move life-changing drug candidates through preclinical development and beyond quickly and effectively.

Our preclinical oncology solutions consist of in vitro and in vivo pharmacology efficacy models, in vivo imaging technologies, in vitro assessments and focal radiation capabilities to support your oncology research programs. Our team helps you explore the effects of drugs and biologics using both human and syngeneic tumor models providing you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough.

300 human xenograft
50 mouse syngeneic models
30 cancer histotypes

Oncology Discovery Capabilities

Immunotherapy & Adoptive Cell Therapy Support

We offer over 50 different syngeneic tumor models, from both solid and disseminated origins, to provide you with many choices to further your immuno-oncology research. We are continually improving and expanding our adoptive cell therapy capabilities.

Featured Technologies

For over a decade, we have offered an industry-leading array of technology platforms to deliver efficient quality results:

Let's start a conversation